Jane Street Portfolio holdings
Jane Street Group, founded in 2000 by Tim Reynolds, Rob Granieri, Marc Gerstein, and Michael Jenkins, is a New York City-based quantitative trading firm renowned for its technological prowess and collaborative problem-solving culture. Specializing in liquidity provision and market-making, it trades a vast array of financial products—including equities, bonds, options, and ETFs—across over 200 venues in 45 countries, handling trillions in securities annually. The firm, which employs over 2,600 people across offices in New York, London, Hong Kong, Amsterdam, Chicago, and Singapore, leverages advanced algorithms and a nearly 70-million-line OCaml codebase to dominate markets, notably ETFs, where it plays a critical role as an authorized participant. With net trading revenues exceeding $10 billion annually in recent years, including a record $10.6 billion in 2023, Jane Street has emerged as a secretive yet powerful force in global finance, outpacing traditional Wall Street giants like Goldman Sachs in trading profitability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.52B |
| 2 |
NVIDIA
NVDA
|
+$732M |
| 3 |
ProShares UltraPro QQQ
TQQQ
|
+$555M |
| 4 |
Dell
DELL
|
+$542M |
| 5 |
Schwab Short-Term US Treasury ETF
SCHO
|
+$421M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$4.18B |
| 2 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$1.29B |
| 3 |
Visa
V
|
+$1.12B |
| 4 |
iShares Core MSCI EAFE ETF
IEFA
|
+$918M |
| 5 |
Broadcom
AVGO
|
+$892M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 2.93% |
| 2 | Consumer Discretionary | 1.52% |
| 3 | Healthcare | 0.84% |
| 4 | Financials | 0.83% |
| 5 | Communication Services | 0.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
8876
SkinHealth Systems
SKIN
$84.1M
| $116K | ﹤0.01% |
80,832
-191,839
| -70% | -$314K |
|
8877
System1
SST
$17.8M
| $116K | ﹤0.01% |
10,359
+4,415
| +74% | +$56.7K |
|
8878
Immunic
IMUX
$191M
| $116K | ﹤0.01% |
7,030
+3,855
| +121% | +$54.9K |
|
8879
PUT
Ginkgo Bioworks
DNA
$533M
| $116K | ﹤0.01% |
14,200
+13,760
| +3,127% | +$138K |
|
8880
Frontier Group Holdings
ULCC
$1.62B
| $116K | ﹤0.01% |
21,628
-170,378
| -89% | -$666K |
|
8881
Quest Resource Holding
QRHC
$30.3M
| $116K | ﹤0.01% |
+14,484
| New | +$124K |
|
8882
Pioneer Bancorp
PBFS
$431M
| $115K | ﹤0.01% |
10,448
-1,918
| -16% | -$20.8K |
|
8883
OFS Capital
OFS
$50.4M
| $115K | ﹤0.01% |
+13,551
| New | +$114K |
|
8884
Outset Medical
OM
$92.9M
| $114K | ﹤0.01% |
11,244
-48,210
| -81% | -$1.43M |
|
|
OPT
8885
DELISTED
Opthea Limited American Depositary Shares
OPT
| $114K | ﹤0.01% |
+26,632
| New | +$71.2K |
|
|
BGFV
8886
DELISTED
Big 5 Sporting Goods
BGFV
| $114K | ﹤0.01% |
54,481
-87,762
| -62% | -$187K |
|
8887
Black Diamond Therapeutics
BDTX
$112M
| $113K | ﹤0.01% |
+26,025
| New | +$142K |
|
8888
KORU Medical Systems
KRMD
$159M
| $113K | ﹤0.01% |
41,259
-52,614
| -56% | -$130K |
|
|
BCOV
8889
DELISTED
Brightcove, Inc.
BCOV
| $113K | ﹤0.01% |
52,084
-11,387
| -18% | -$25.4K |
|
8890
Angi Inc
ANGI
$187M
| $112K | ﹤0.01% |
4,358
-491
| -10% | -$11.8K |
|
8891
Clarus
CLAR
$146M
| $112K | ﹤0.01% |
24,955
-10,667
| -30% | -$53.8K |
|
8892
CALL
Annovis Bio
ANVS
$79.1M
| $112K | ﹤0.01% |
13,900
-40,500
| -74% | -$379K |
|
|
NFGC
8893
New Found Gold
NFGC
$649M
| $111K | ﹤0.01% |
43,547
-18,128
| -29% | -$49.7K |
|
8894
Sera Prognostics
SERA
$80.3M
| $111K | ﹤0.01% |
14,225
+2,826
| +25% | +$20.5K |
|
8895
Greenfire Resources
GFR
$803M
| $111K | ﹤0.01% |
+14,862
| New | +$106K |
|
|
SLI
8896
Standard Lithium
SLI
$635M
| $110K | ﹤0.01% |
68,623
-2,898
| -4% | -$3.73K |
|
8897
PMV Pharmaceuticals
PMVP
$63.5M
| $110K | ﹤0.01% |
74,089
-89,957
| -55% | -$139K |
|
8898
Lifezone Metals
LZM
$357M
| $110K | ﹤0.01% |
15,749
+2,118
| +16% | +$14.8K |
|
8899
Delcath Systems
DCTH
$556M
| $110K | ﹤0.01% |
+12,208
| New | +$106K |
|
8900
CALL
Prospect Capital
PSEC
$1.14B
| $110K | ﹤0.01% |
20,600
-8,600
| -29% | -$45.6K |
|
Similar funds
Jane Street's Q3 2024 Portfolio in Review
As of Q3 2024, Jane Street held 10,828 positions worth $453B, up 3.6% from $438B the previous quarter. Its ten largest holdings account for 44% of the portfolio.
Jane Street withdrew a net $18.5B in Q3 2024, closing 1,349 positions and reducing 4,327 holdings. Its most notable exit was iShares Core MSCI International Developed Markets ETF, an estimated $290M position sold in full.
By sector, the portfolio is most concentrated in Technology at 2.9% of assets, down from 4.6% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Jane Street opened a new position in Schwab Short-Term US Treasury ETF worth $424M.
- Jane Street's largest Q3 2024 buy was Schwab Short-Term US Treasury ETF: 17,304,274 shares worth $424M.
- Jane Street added most to State Street SPDR S&P 500 ETF Trust in Q3 2024, an estimated $2.52B increase.
- Jane Street's biggest Q3 2024 reduction was Apple, cutting an estimated $4.18B.
- Jane Street fully exited iShares Core MSCI International Developed Markets ETF in Q3 2024, selling an estimated $290M.
- Jane Street's ten largest holdings make up 44% of its $453B portfolio in Q3 2024.
- Jane Street opened 1,593 new positions and closed 1,349 in Q3 2024.
- Jane Street's portfolio value rose 3.6% quarter-over-quarter to $453B.
Based on Jane Street's 13F filing for Q3 2024, filed 15 Nov 2024.